Boston Scientific Corporation, U.S.
Type of Action
Federal
Last Updated
FTC Matter/File Number
971 0116
Displaying 1821 - 1840 of 2076
FTC Charges Unocal with Anticompetitive Conduct Related to Reformulated Gasoline
Date
The Federal Trade Commission today issued an administrative complaint against Union Oil Company of California (Unocal) for allegedly committing fraud in connection with regulatory proceedings before...
FTC Competition Director Announces Best Practices for Merger Investigations
Date
Presenting keynote remarks at an annual conference on "Current Topics in Merger and Antitrust Enforcement" in Washington, DC, today Federal Trade Commission Competition Director Joe Simons announced...
FTC Releases Health Care and Competition Law and Policy Workshop Materials
Date
The Federal Trade Commission today released the materials relating to the workshop on Health Care Competition Law and Policy, held on September 9-10, 2002. The workshop focused on the implications of...
Oct08
Possible Anticompetitive Efforts to Restrict Competition on the Internet
-
The FTC hosted a public workshop to explore how certain state regulations and private business practices may be having significantly anticompetitive effects on e-commerce. Some private estimates...
Sep09
Workshop on Health Care and Competition Law and Policy
-
The FTC held a public workshop on the implications of competition law and policy for health care financing and delivery. The workshop considered the impact of competition law and policy on the cost...
Federal Trade Commission Announces Formation of Merger Litigation Task Force
Date
Joe Simons, Director of the Federal Trade Commission's Bureau of Competition, today announced the formation of the Merger Litigation Task Force, which will be headed by Michael Cowie, an Assistant...
Physician Integrated Services of Denver, Inc., Michael J. Guese, M.D., and Marcia L. Brauchler
A consent order settled charges that a Denver, Colorado physician organization and its members, its president, Dr. M. J. Guese, and its non-physician consultant, M. A. Brauchler, increased fees for services through collective boycotts and agreements in a effort to fix the prices they would receive from health care insurance payers. The order prohibits the organization and its members and other respondents from entering into any agreement with insurance payers or providers to negotiate on behalf of the physicians group.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0110173
Aurora Associated Primary Care Physicians, L.L.C., Richard A. Patt, M.D., Gary L. Gaede, M.D., and Marcia L. Brauchler
A consent order settled charges that the organization of internists, pediatricians, family physicians and general practitioners in the Aurora, Colorado area engaged in boycotts and entered into collective negotiations with health care insurers in an effort to increase the costs of physician services. The order prohibits the organization from entering into any agreement with insurance payers or providers to negotiate fees on behalf of the physicians group.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0110174
Biovail Corporation
The Commission charged Biovail Corporation with illegally acquiring an exclusive patent license for Tiazac, a pharmaceutical used to treat high blood pressure and chronic chest pain. The complaint further alleged that Biovail, in an effort to maintain its monopoly, wrongfully listed the acquired license in the U.S. Food and Drug Administration’s “Orange Book” for the purpose of blocking generic competition to its branded Tiazac. The consent order requires Biovail to divest part of its exclusive rights to DOV; prohibits the firm from taking any action that would trigger additional statutory stays on final FDA approval of a generic form of Tiazac; and also prohibits Biovail from wrongfully listing any patents in the Orange Book for a product for which the company already has an New Drug Application from the FDA.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
011 0094
Docket Number
C-4060
Jun03
FTC Merger Best Practices
-
The FTC held a series of public workshops regarding modifications and improvements to the Commission's merger investigations process and its use of specific remedy provisions. The Commission used this...
Addressing Competitive Concerns in Core Markets, FTC Approves Bayer AG'S Acquisition of Aventis CropScience Holdings S.A.
Date
The Federal Trade Commission today announced a proposed consent order with Bayer AG (Bayer) and Aventis S.A. (Aventis) that will allow Bayer's proposed purchase of Aventis's subsidiary Aventis...
Valero Energy Corporation and Ultramar Diamond Shamrock Corporation
The consent order permitted Valero to complete its $6 billion merger with Ultramar Diamond Shamrock Corporation, but required the divestiture of Ultramar's Golden Eagle Refinery, bulk gasoline contracts, and 70 Ultramar retail service stations in Northern California to a Commission-approved acquirer. According to the complaint, the merger as originally proposed, would have lessened competition in two refining markets in California resulting in consumers paying more than $150million annually if the price of CARB gasoline increased just one cent per gallon. CARB gasoline meets the specifications of the California Air Resources Board.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0110141
Docket Number
C-4031
Deutsche Gelatine-Fabriken Stoess AG and Goodman Fielder Limited
The Commission authorized staff to seek a preliminary injunction to block DGF’s proposed acquisition of Leiner Davis Gelatin Corporation and its Goodman Fielder USA, Inc. subsidiary. According to the Commission this transaction, if allowed to proceed as planned, would increase the likelihood of anticompetitive activity in the U.S. market for pigskin and beef hide gelatin, used by the food industry as an ingredient in edible products and by the pharmaceutical industry to produce capsules and tablets. The combination of the two firms would account for more than 50 percent of the relevant market in the U.S. A proposed consent agreement designed to remedy the significant antitrust concerns was accepted for public comment March 7, 2002; the consent order was finalized April 17, 2002.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
011 0117
Docket Number
C-4045
FTC Seeks Public Comments on the Use of Disgorgement as a Remedy for Competition Violations
Date
The Federal Trade Commission today approved publication of a Federal Register notice seeking public comments on the use of disgorgement as a remedy for competition violations, including those...
Statement of Susan A. Creighton, Deputy Director, Bureau of Competition Regarding FTC Settlement with Hearst Corporation
Date
The staff of the Federal Trade Commission has negotiated an agreement with The Hearst Corporation (Hearst), which staff will propose to the Commission as a way to settle a permanent injunction action...
The Hearst Corporation Settles Charges of Filing Incomplete Pre-merger Report
Date
The Federal Trade Commission today announced that The Hearst Trust and its wholly owned subsidiary, The Hearst Corporation (Hearst), have agreed to settle charges that it failed to include required...
Displaying 1821 - 1840 of 2076